(Q57278906)

English

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (English)

0 references

0 references

1 reference

V. Kataja

2

0 references

author name string

B. Escudier

series ordinal

1

0 references

publication date

1 May 2010

0 references

published in

Annals of Oncology

0 references

volume

21

0 references

issue

Supplement 5

0 references

page(s)

v137-v139

0 references

cites work

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

The role of cytoreductive nephrectomy in the era of molecular targeted therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Sunitinib in patients with metastatic renal cell carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ206

retrieved

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDQ206

0 references

PubMed publication ID

20555064

0 references

(Q57278906)

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)